Abstract
Objective
To compare the knowledge, beliefs, and practices regarding HPV vaccination among mothers of vaccine-eligible girls in Mexico and the USA.
Methods
Similar samples of Mexican mothers with vaccine-eligible daughters were surveyed at two clinics in Cuernavaca, Morelos, from July to October 2012 (n = 200) and at two clinics in Oxnard, California, from August to November 2013 (n = 200).
Results
Although mothers in the USA had less knowledge and more negative attitudes toward the vaccine than their counterparts in Mexico, vaccine uptake rates were higher in the USA (49% vs. 40%). US mothers were more likely to have discussed and been offered the HPV vaccine by a clinician than mothers in Mexico. In multivariate analyses, having been offered the HPV vaccine was the most important predictor of vaccine uptake.
Conclusions
Our results suggest that healthcare access or other system, clinic, or provider factors are the main drivers of vaccine receipt in this binational sample of Mexican mothers. Interventions and programs that encourage clinicians to offer the HPV vaccine should be developed to increase vaccine uptake in both countries.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
American Cancer Society (2018) Key statistics for cervical cancer? https://www.cancer.org/cancer/cervical-cancer/about/key-statistics.html. Accessed 7 July 2018
American Cancer Society, California Department of Public Health, California Cancer Registry (2017) California cancer facts & figures 2017. American Cancer Society, Inc. California Division, Alameda. http://www.ccrcal.org/pdf/Reports/ACS_2017_FF.pdf. Accessed 7 July 2018
Bastani R, Glenn BA, Taylor VM, Chen MS Jr, Nguyen TT, Stewart SL, Maxwell AE (2010) Integrating theory into community interventions to reduce liver cancer disparities: the Health Behavior Framework. Prev Med 50(1–2):63–67. https://doi.org/10.1016/j.ypmed.2009.08.010
Bastani R, Glenn BA, Tsui J, Chang LC, Marchand EJ, Taylor VM, Singhal R (2011) Understanding suboptimal human papillomavirus vaccine uptake among ethnic minority girls. Cancer Epidemiol Biomark Prev 20(7):1463–1472. https://doi.org/10.1158/1055-9965.EPI-11-0267
Berenson AB (2015) An update on barriers to adolescent human papillomavirus vaccination in the USA. Expert Rev Vaccines 14:1377–1384. https://doi.org/10.1586/14760584.2015.1078240
Bruni L, Diaz M, Barrionuevo-Rosas L, Herrero R, Bray F, Bosch FX, de Sanjosé S, Castellsagué X (2016) Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis. Lancet Glob Health 4(7):e453–e463. https://doi.org/10.1016/s2214-109x(16)30099-7
Bruni L, Barrionuevo-Rosas L, Albero G, Serrano B, Mena M, Gómez D, Muñoz J, Bosch FX, de Sanjosé S (2017) ICO information centre on HPV and cancer (HPV information centre). Human papillomavirus and related diseases in Mexico. Summary report. https://www.hpvcentre.net/statistics/reports/MEX.pdf. Accessed 7 July 2018
Bynum SA, Staras SA, Malo TL, Giuliano AR, Shenkman E, Vadaparampil ST (2014) Factors associated With Medicaid providers’ recommendation of the HPV vaccine to low-income adolescent girls. J Adolesc Health 54(2):190–196. https://doi.org/10.1016/j.jadohealth.2013.08.006
Centers for Disease Control and Prevention (2011) Progress toward implementation of human papillomavirus vaccination—the Americas, 2006–2010. MMWR Morb Mortal Wkly Rep 60(40):1382–1384. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6040a2.htm. Accessed 7 July 2018
Centers for Disease Control and Prevention (2014) Vaccines for children program (VFC). https://www.cdc.gov/vaccines/programs/vfc/about/index.html. Accessed 7 July 2018
Centers for Disease Control and Prevention (2018) Cervical cancer statistics. https://www.cdc.gov/cancer/cervical/statistics/index.htm. Accessed 7 July 2018
Elam-Evans LD, Yankey D, Jeyarajah J, Singleton JA, Curtis RC, MacNeil J, Hariri S, Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC) (2014) National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2013. MMMW 63(29):625–633. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6329a4.htm. Accessed 7 July 2018
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386. https://doi.org/10.1002/ijc.29210
Fernandez ME, McCurdy SA, Arvey SR, Tyson SK, Morales-Campos D, Flores B, Useche B, Mitchell-Bennett L, Sanderson M (2009) HPV knowledge, attitudes, and cultural beliefs among Hispanic men and women living on the Texas-Mexico border. Ethn Health 14(6):607–624. https://doi.org/10.1080/13557850903248621
Gerend MA, Zapata C, Reyes E (2013) Predictors of human papillomavirus vaccination among daughters of low-income Latina mothers: the role of acculturation. J Adolesc Health 53(5):623–629. https://doi.org/10.1016/j.jadohealth.2013.06.006
Glenn BA, Tsui J, Singhal R, Sanchez L, Nonzee NJ, Chang LC, Taylor VM, Bastani R (2015) Factors associated with HPV awareness among mothers of low-income ethnic minority adolescent girls in Los Angeles. Vaccine 33(2):289–293. https://doi.org/10.1016/j.vaccine.2014.11.032
Instituto Nacional de Estadística y Geografía (INEGI) (2013) Encuesta Nacional de Empleo y Seguridad Social (ENESS) http://www.beta.inegi.org.mx/proyectos/enchogares/modulos/eness/2013/. Accessed 7 July 2018
Javanbakht M, Stahlman S, Walker S, Gottlieb S, Markowitz L, Liddon N, Plant A, Guerry S (2012) Provider perceptions of barriers and facilitators of HPV vaccination in a high-risk community. Vaccine 30(30):4511–4516. https://doi.org/10.1016/j.vaccine.2012.04.062
Kepka DL, Ulrich AK, Coronado GD (2012) Low knowledge of the three-dose HPV vaccine series among mothers of rural Hispanic adolescents. J Health Care Poor Underserved 23(2):626–635. https://doi.org/10.1353/hpu.2012.0040
Kepka D, Warner EL, Kinney AY, Spigarelli MG, Mooney K (2015) Low human papillomavirus (HPV) vaccine knowledge among Latino parents in Utah. J Immigr Minor Health 17(1):125–131. https://doi.org/10.1007/s10903-014-0003-1
Lazcano-Ponce EC, Moss S, Alonso R, Salmerón J, Hernández M (1999) Cervical cancer screening in developing countries: why is it ineffective? The case of Mexico. Arch Med Res 30(3):240–250
Liu L, Wang Y, Sherman RL, Cockburn M, Deapen D (eds) (2016) Cancer in Los Angeles county: trends by race/ethnicity, 1976–2012. Los Angeles Cancer Surveillance Program, University of Southern California. http://keck.usc.edu/cancer-surveillance-program/wp-content/uploads/sites/166/2016/08/Cancer-in-LA-2016.pdf. Accessed 7 July 2018
Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER (2007) Quadrivalent human papillomavirus vaccine: recommendations of the advisory committee on immunization practices (ACIP). MMWR 56 (RR-2):1–24. https://www.cdc.gov/mmwr/PDF/rr/rr5602.pdf. Accessed 7 July 2018
Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER (2014) Human papillomavirus vaccination: recommendations of the advisory committee on immunization practices (ACIP). MMWR 63(5):1–30. https://www.cdc.gov/mmwr/pdf/rr/rr6305.pdf. Accessed 7 July 2018
Newman PA, Logie CH, Lacombe-Duncan A, Baiden P, Tepjan S, Rubincam C, Doukas N, Asey F (2018) Parents’ uptake of human papillomavirus vaccines for their children: a systematic review and meta-analysis of observational studies. BMJ Open 8(4):e019206. https://doi.org/10.1136/bmjopen-2017-019206
Perkins RB, Anderson BL, Gorin SS, Schulkin JA (2013) Challenges in cervical cancer prevention. Am J Prev Med 45(2):175–181. https://doi.org/10.1016/j.amepre.2013.03.019
Petrosky E, Bocchini JA, Hariri S, Chesson H, Curtis CR, Saraiya M, Unger ER, Markowitz LE (2015) Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMMW 64(11);300–304. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6411a3.htm. Accessed 7 July 2018
Ramírez-Rios AD, Bonnez W (2013) Attitudes affecting the potential use of human papillomavirus vaccination: a survey of health promotion students in Mexico City. J Community Health. https://doi.org/10.1007/s10900-013-9770-1
Sánchez Anguiano LF, Lechuga Quiñones AM, Milla Villeda RH, Lares Bayona EF (2013) Knowledge and acceptance of vaccine against human papillomavirus among mothers of students from Durango City, Mexico. Ginecol Obstet Mex 81(2):77–85
Sussman AL, Helitzer D, Bennett A, Solares A, Lanoue M, Getrich CM (2015) Catching up with the HPV vaccine: challenges and opportunities in primary care. Ann Fam Med 13(4):354–360. https://doi.org/10.1370/afm.1821 ; PMCID: PMC4508177
Tsui J, Singhal R, Rodriguez HP, Gee GC, Glenn BA, Bastani R (2013) Proximity to safety-net clinics and HPV vaccine uptake among low-income, ethnic minority girls. Vaccine 31(16):2028–2034. https://doi.org/10.1016/j.vaccine.2013.02.046;PMCID:PMC3629820
Vanslyke JG, Baum J, Plaza V, Otero M, Wheeler C, Helitzer DL (2008) HPV and cervical cancer testing and prevention: knowledge, beliefs, and attitudes among Hispanic women. Qual Health Res 18(5):584–596. https://doi.org/10.1177/1049732308315734
Walker TY, Elam-Evans LD, Singleton JA, Yankey D, Markowitz LE, Fredua B, Williams CL, Meyer SA, Stokley S (2017) National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2016. MMWR Morb Mortal Wkly Rep 66:874–882. https://doi.org/10.15585/mmwr.mm6633a2
Wentzell E, Flores YN, Salmerón J, Bastani R (2016) Factors influencing Mexican women’s decisions to vaccinate daughters against HPV in the United States and Mexico. Fam Community Health 39(4):310–319. https://doi.org/10.1097/FCH.0000000000000102
Ylitalo KR, Lee H, Mehta NK (2013) Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US National Immunization Survey. Am J Public Health 103(1):164–169. https://doi.org/10.2105/AJPH.2011.300600
Acknowledgements
This work was supported by the Programa de Investigación en Migracion y Salud (PIMSA), Berkeley, CA, the Mexican Institute of Social Security [grant number FIS/IMSS/PROT/G11/970], and the UCLA Kaiser Permanente Center for Health Equity. YNF was also supported by NIH/NCI K07CA197179. The authors would like to thank the study participants and our collaborators at Clinicas del Camino Real (Dr. Gagan Pawar, Patricia Andrade and Laura Aguiniga), IMSS (Griselda Diaz, Lucy Cruz), and UCLA (Mayra Macias).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests to disclose.
Ethical standard
All study procedures were performed in accordance with the ethical standards of the UCLA and IMSS research committees and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Flores, Y.N., Salmerón, J., Glenn, B.A. et al. Clinician offering is a key factor associated with HPV vaccine uptake among Mexican mothers in the USA and Mexico: a cross-sectional study. Int J Public Health 64, 323–332 (2019). https://doi.org/10.1007/s00038-018-1176-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00038-018-1176-5